Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14041
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSukketsiri W.
dc.contributor.authorPorntadavity S.
dc.contributor.authorPhivthong-ngam L.
dc.contributor.authorLawanprasert S.
dc.date.accessioned2021-04-05T03:32:56Z-
dc.date.available2021-04-05T03:32:56Z-
dc.date.issued2013
dc.identifier.issn0260437X
dc.identifier.other2-s2.0-84878193221
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14041-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84878193221&doi=10.1002%2fjat.1789&partnerID=40&md5=5ddadf00a425f7bb17c181c28b08d7db
dc.description.abstractLead is an environmental toxicant of great concern for humans and animals. Lead-induced liver damage and malfunction are partly due to a disturbance of the cellular antioxidant balance. Paraoxonase 1 (PON1) and PON2 are highly expressed in the liver and have been proposed as antioxidative enzymes. In this study, the effects of lead on PON1 and PON2 activities were investigated in human hepatoma HepG2 cells by exposing the cells to various concentrations of lead acetate for 24, 48, or 72h. The results show that a significant increase in reactive oxygen species was observed even at the lowest concentration of lead treatment. However, only the highest concentration of lead significantly influenced cell viability. Lead had no influence on cell-associated PON1 activity, but it significantly decreased cytoplasmic PON2 activity in a concentration- and time-dependent manner. This reduction was rescued by the addition of calcium. A significant increase of PON2 transcript was observed by real-time polymerase chain reaction, while PON2 protein expression did not change in the western blot analysis. Taken together, these results indicate that lead reduces PON2, but not PON1, activity and that this reduction is reversed by calcium. Lead-induced oxidative stress and decreased PON2 activity lead to the upregulation of PON2 transcript. © 2012 John Wiley & Sons, Ltd.
dc.subjectaryldialkylphosphatase 1
dc.subjectaryldialkylphosphatase 2
dc.subjectcalcium
dc.subjectlead acetate
dc.subjectreactive oxygen metabolite
dc.subjectadult
dc.subjectarticle
dc.subjectcancer cell culture
dc.subjectcell lysate
dc.subjectcell viability
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectenzyme activity
dc.subjectenzyme inhibition
dc.subjecthepatoma cell
dc.subjecthuman
dc.subjecthuman cell
dc.subjectin vitro study
dc.subjectliver cell carcinoma
dc.subjectliver toxicity
dc.subjectmolecular size
dc.subjectoxidative stress
dc.subjectpriority journal
dc.subjectprotein expression
dc.subjectreal time polymerase chain reaction
dc.subjectRNA extraction
dc.subjectspectrophotometry
dc.subjecttreatment duration
dc.subjectupregulation
dc.subjectWestern blotting
dc.subjectAryldialkylphosphatase
dc.subjectBlotting, Western
dc.subjectCalcium Chloride
dc.subjectCarcinoma, Hepatocellular
dc.subjectCell Line, Tumor
dc.subjectCell Survival
dc.subjectDrug-Induced Liver Injury
dc.subjectEnzyme Inhibitors
dc.subjectHumans
dc.subjectIndicators and Reagents
dc.subjectLiver Neoplasms
dc.subjectOrganometallic Compounds
dc.subjectReactive Oxygen Species
dc.subjectReal-Time Polymerase Chain Reaction
dc.subjectRNA
dc.subjectAnimalia
dc.titleLead inhibits paraoxonase 2 but not paraoxonase 1 activity in human hepatoma HepG2 cells
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationJournal of Applied Toxicology. Vol 33, No.7 (2013), p.631-637
dc.identifier.doi10.1002/jat.1789
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.